A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Issue 14 (6th December 2022)

• Record Type: Journal Article
• Authors: Nath, Karthik; Shekarkhand, Tala; Salcedo, Meghan; Derkach, Andriy; Rueda, Siobhan; Chansakul, Aisara; Hulcrantz, Malin; Korde, Neha; Shah, Urvi A.; Tan, Carlyn; Chung, David J.; Lahoud, Oscar B.; Hassoun, Hani; Lesokhin, Alexander M.; Landau, Heather J.; Shah, Gunjan; Scordo, Michael; Giralt, Sergio A.; Usmani, Saad Z.; Roshal, Mikhail; Landgren, Ola; Mailankody, Sham
• Is Part Of: Leukemia & lymphoma. Volume 63:Issue 14(2022)
• Page Start: 3488
• Page End: 3492
• Publication Date: 2022-12-06
• Subjects: Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2022.2131417
• Languages: English
• ISSNs: 1042-8194